CRISPR and CRISPR-associated (Cas) Genes Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Vector-based Cas , DNA-free Cas); Application (Genome Engineering, Disease models, Functional Genomics, Knockdown/activation, Others); End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations) and Geography

Report Code: TIPRE00006876 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

CRISPR and CRISPR-Associated (Cas) Genes are genome editing tools that allow scientists to make changes to DNA. CRISPR-Cas9 stands for CRISPR-associated protein 9 and clustered regularly interspaced short palindromic repeats. CRISPR and CRISPR-Associated (Cas) Genes have gained a lot of popularity in recent years because they offer genome editing methods that are cheaper, faster, more accurate, and more effective.

MARKET SCOPE

The "Global CRISPR and CRISPR-Associated (Cas) Genes Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the CRISPR and CRISPR-associated (Cas) genes market with detailed market segmentation by product, application and end user. The report provides key statistics on the market status of the leading CRISPR and CRISPR-associated (Cas) genes market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on product the market is segmented as, vector-based Cas and DNA-free Cas.
  •   Based on application the market is segmented as, genome engineering, disease models, functional genomics, knockdown/activation and others.
  •   Based on end user the market is segmented as, biotechnology and pharmaceutical companies, academic and government research institutes, contract research organizations.

MARKET DYNAMICS
Drivers:

  •   Advancements in biopharmaceutical and pharmaceutical industries is the key driver for the market growth.
  •   Rising prevalence of genetic as well as chronic disorders along with increasing adoption of CRISPR.
  •   Increasing utilization of genome editing technologies is also expected to spur the market growth.

Restraints:

  •   However, presence of intense competition among the market players along with high cost associated with the study are likely to restrain market growth during the forecast period.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The CRISPR and CRISPR-associated (Cas) genes market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the CRISPR and CRISPR-associated (Cas) genes market in these regions.

IMPACT OF COVID-19 ON CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the CRISPR and CRISPR-associated (Cas) genes market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from CRISPR and CRISPR-associated (Cas) genes market are anticipated to lucrative growth opportunities in the future with the rising demand for CRISPR and CRISPR-associated (Cas) genes in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the CRISPR and CRISPR-associated (Cas) genes market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Merck KGaA
  •   Bio-Rad Laboratories, Inc
  •   CRISPR Therapeutics
  •   Thermo Fisher Scientific, Inc.
  •   Mirus Bio LLC
  •   Editas Medicine
  •   Takara Bio Inc
  •   Horizon Discovery Ltd
  •   Lonza
  •   Intellia Therapeutics, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 CRISPR And CRISPR-associated (Cas) Genes Market - By Product
1.3.2 CRISPR And CRISPR-associated (Cas) Genes Market - By Application
1.3.3 CRISPR And CRISPR-associated (Cas) Genes Market - By End User
1.3.4 CRISPR And CRISPR-associated (Cas) Genes Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET - GLOBAL MARKET ANALYSIS
6.1. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES - GLOBAL MARKET OVERVIEW
6.2. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. VECTOR-BASED CAS
7.3.1. Overview
7.3.2. Vector-based Cas Market Forecast and Analysis
7.4. DNA-FREE CAS
7.4.1. Overview
7.4.2. DNA-free Cas Market Forecast and Analysis
8. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GENOME ENGINEERING
8.3.1. Overview
8.3.2. Genome Engineering Market Forecast and Analysis
8.4. DISEASE MODELS
8.4.1. Overview
8.4.2. Disease models Market Forecast and Analysis
8.5. FUNCTIONAL GENOMICS
8.5.1. Overview
8.5.2. Functional Genomics Market Forecast and Analysis
8.6. KNOCKDOWN/ACTIVATION
8.6.1. Overview
8.6.2. Knockdown/activation Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Biotechnology and Pharmaceutical Companies Market Forecast and Analysis
9.4. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic and Government Research Institutes Market Forecast and Analysis
9.5. CONTRACT RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Contract Research Organizations Market Forecast and Analysis

10. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America CRISPR And CRISPR-associated (Cas) Genes Market Overview
10.1.2 North America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.1.3 North America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.1.4 North America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.1.5 North America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.1.6 North America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.1.6.1 United States CRISPR And CRISPR-associated (Cas) Genes Market
10.1.6.1.1 United States CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.1.6.1.2 United States CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.1.6.1.3 United States CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.1.6.2 Canada CRISPR And CRISPR-associated (Cas) Genes Market
10.1.6.2.1 Canada CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.1.6.2.2 Canada CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.1.6.2.3 Canada CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.1.6.3 Mexico CRISPR And CRISPR-associated (Cas) Genes Market
10.1.6.3.1 Mexico CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.1.6.3.2 Mexico CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.1.6.3.3 Mexico CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.2. EUROPE
10.2.1 Europe CRISPR And CRISPR-associated (Cas) Genes Market Overview
10.2.2 Europe CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.2.3 Europe CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.2.4 Europe CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.2.5 Europe CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.2.6 Europe CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.2.6.1 Germany CRISPR And CRISPR-associated (Cas) Genes Market
10.2.6.1.1 Germany CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.2.6.1.2 Germany CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.2.6.1.3 Germany CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.2.6.2 France CRISPR And CRISPR-associated (Cas) Genes Market
10.2.6.2.1 France CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.2.6.2.2 France CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.2.6.2.3 France CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.2.6.3 Italy CRISPR And CRISPR-associated (Cas) Genes Market
10.2.6.3.1 Italy CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.2.6.3.2 Italy CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.2.6.3.3 Italy CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.2.6.4 Spain CRISPR And CRISPR-associated (Cas) Genes Market
10.2.6.4.1 Spain CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.2.6.4.2 Spain CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.2.6.4.3 Spain CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.2.6.5 United Kingdom CRISPR And CRISPR-associated (Cas) Genes Market
10.2.6.5.1 United Kingdom CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.2.6.5.2 United Kingdom CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.2.6.5.3 United Kingdom CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.2.6.6 Rest of Europe CRISPR And CRISPR-associated (Cas) Genes Market
10.2.6.6.1 Rest of Europe CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.2.6.6.2 Rest of Europe CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.2.6.6.3 Rest of Europe CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market Overview
10.3.2 Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.3.3 Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.3.6.1 Australia CRISPR And CRISPR-associated (Cas) Genes Market
10.3.6.1.1 Australia CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.3.6.1.2 Australia CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.3.6.1.3 Australia CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.3.6.2 China CRISPR And CRISPR-associated (Cas) Genes Market
10.3.6.2.1 China CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.3.6.2.2 China CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.3.6.2.3 China CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.3.6.3 India CRISPR And CRISPR-associated (Cas) Genes Market
10.3.6.3.1 India CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.3.6.3.2 India CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.3.6.3.3 India CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.3.6.4 Japan CRISPR And CRISPR-associated (Cas) Genes Market
10.3.6.4.1 Japan CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.3.6.4.2 Japan CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.3.6.4.3 Japan CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.3.6.5 South Korea CRISPR And CRISPR-associated (Cas) Genes Market
10.3.6.5.1 South Korea CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.3.6.5.2 South Korea CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.3.6.5.3 South Korea CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.3.6.6 Rest of Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market
10.3.6.6.1 Rest of Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.3.6.6.2 Rest of Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.3.6.6.3 Rest of Asia-Pacific CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market Overview
10.4.2 Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.4.3 Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa CRISPR And CRISPR-associated (Cas) Genes Market
10.4.6.1.1 South Africa CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.4.6.1.2 South Africa CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.4.6.1.3 South Africa CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.4.6.2 Saudi Arabia CRISPR And CRISPR-associated (Cas) Genes Market
10.4.6.2.1 Saudi Arabia CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.4.6.2.2 Saudi Arabia CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.4.6.2.3 Saudi Arabia CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.4.6.3 U.A.E CRISPR And CRISPR-associated (Cas) Genes Market
10.4.6.3.1 U.A.E CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.4.6.3.2 U.A.E CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.4.6.3.3 U.A.E CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.4.6.4 Rest of Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market
10.4.6.4.1 Rest of Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.4.6.4.2 Rest of Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.4.6.4.3 Rest of Middle East and Africa CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America CRISPR And CRISPR-associated (Cas) Genes Market Overview
10.5.2 South and Central America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.5.3 South and Central America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.5.4 South and Central America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.5.5 South and Central America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.5.6 South and Central America CRISPR And CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil CRISPR And CRISPR-associated (Cas) Genes Market
10.5.6.1.1 Brazil CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.5.6.1.2 Brazil CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.5.6.1.3 Brazil CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.5.6.2 Argentina CRISPR And CRISPR-associated (Cas) Genes Market
10.5.6.2.1 Argentina CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.5.6.2.2 Argentina CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.5.6.2.3 Argentina CRISPR And CRISPR-associated (Cas) Genes Market by End User
10.5.6.3 Rest of South and Central America CRISPR And CRISPR-associated (Cas) Genes Market
10.5.6.3.1 Rest of South and Central America CRISPR And CRISPR-associated (Cas) Genes Market by Product
10.5.6.3.2 Rest of South and Central America CRISPR And CRISPR-associated (Cas) Genes Market by Application
10.5.6.3.3 Rest of South and Central America CRISPR And CRISPR-associated (Cas) Genes Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET, KEY COMPANY PROFILES
12.1. MERCK KGAA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIO-RAD LABORATORIES, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CRISPR THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMO FISHER SCIENTIFIC, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MIRUS BIO LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EDITAS MEDICINE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TAKARA BIO INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HORIZON DISCOVERY LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LONZA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INTELLIA THERAPEUTICS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Merck KGaA
- Bio-Rad Laboratories, Inc
- CRISPR Therapeutics
- Thermo Fisher Scientific, Inc.
- Mirus Bio LLC
- Editas Medicine
- Takara Bio Inc
- Horizon Discovery Ltd
- Lonza
- Intellia Therapeutics, Inc.
- GenScript
- Synthego
- Mammoth Biosciences
- Beam Therapeutics
- Hera BioLabs
TIPRE00006876
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking